Yu Qiong, Hu Guo-Hua, Zhang Xue-Yuan, Ji Chang-You, Yang Hua, Gao Ming-Hua, Hong Su-Ling
Department of Otorhinolaryngology, First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2011 Feb;46(2):123-7.
To investigate the survival rate and prognostic factors of laryngeal carcinoma patients with no surgery, radiotherapy or chemotherapy.
One hundred and sixty-seven laryngeal carcinoma cases with no surgery, radiotherapy or chemotherapy were analyzed retrospectively. Survival rates were calculated by Kaplan-Meier product-limit method. With univariate analysis, comparisons among/between groups were performed using Log-rank test. Multivariate analysis was carried out using Cox proportional hazard model.
Overall survival time was (16.0 ± 1.4) months (x(-) ± s), overall 1- and 2-year survival rates were 56.4% and 26.5%, respectively. No patient survived over 5 years in these cases who had been diagnosed more than 5 years (except for those who lost). Univariate analysis showed that primary site, pathological grade, T-stage, N-stage and clinical stage were significant prognostic factors for the survival of the patients (P < 0.05). The survival rates of laryngeal carcinoma whether with tracheotomy were no statistically significant (P > 0.05). Multivariate analysis showed survival rates statistically correlated with T stage and N stage (hazard ratio were 1.812 and 1.557, P < 0.05).
The development of laryngeal carcinoma course was faster, without treatment to the tumor itself, even if palliative surgical such as tracheostomy would not improve the survival rate. In laryngeal carcinoma patients with no surgery, radiotherapy or chemotherapy, the factors affecting the survival rates include primary site, pathological grade, T-stage, N-stage and clinical stage, and of them, T-stage and N-stage are the independent prognostic factors.
探讨未接受手术、放疗或化疗的喉癌患者的生存率及预后因素。
回顾性分析167例未接受手术、放疗或化疗的喉癌病例。采用Kaplan-Meier乘积限法计算生存率。单因素分析时,组间比较采用Log-rank检验。多因素分析采用Cox比例风险模型。
总生存时间为(16.0±1.4)个月(x(-)±s),1年和2年总生存率分别为56.4%和26.5%。在这些已确诊超过5年的病例中(除失访者外),无患者生存超过5年。单因素分析显示,原发部位、病理分级、T分期、N分期和临床分期是生存的重要预后因素(P<0.05)。喉癌患者是否行气管切开术的生存率差异无统计学意义(P>0.05)。多因素分析显示,生存率与T分期和N分期具有统计学相关性(风险比分别为1.812和1.557,P<0.05)。
喉癌病程发展较快,未对肿瘤本身进行治疗,即使是气管切开等姑息性手术也不能提高生存率。在未接受手术、放疗或化疗的喉癌患者中,影响生存率的因素包括原发部位、病理分级、T分期、N分期和临床分期,其中T分期和N分期是独立的预后因素。